Skip to main content
. 2023 May 9;67(6):e01531-22. doi: 10.1128/aac.01531-22

FIG 6.

FIG 6

In silico strategy to identify M. tuberculosis QcrC inhibitors. (A) Identification of region of interest in the QcrC functional domain. (B) Analysis of linker residue differences in QcrC between M. tuberculosis and M. smegmatis. Mtb, M. tuberculosis.